We are live on ! Find out more
SBBP

Strongbridge Biopharma plc.
SBBP

Delisted

SBBP was delisted on the 5th of October, 2021.

Back to rankings

Fund managers haven’t disclosed any holdings of SBBP yet.

SBBP Hedge Fund Activity: Q4 2021 in Review

0 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Strongbridge Biopharma plc. (SBBP) for Q4 2021, worth a combined $0 — down 100% from $69.8M a quarter earlier.

Sellers outnumbered buyers: 49 funds closed out of SBBP and 0 opened new positions — a net loss of 49 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Caxton Corporation, exiting entirely with an estimated $16.4M sold.

  • 0 institutional investors held Strongbridge Biopharma plc. (SBBP) as of Q4 2021, down from 49 in Q3 2021.
  • Funds reported $0 of Strongbridge Biopharma plc. stock for Q4 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Strongbridge Biopharma plc. positions in Q4 2021 and 49 closed out, a net change of -49 holders.
  • The largest Strongbridge Biopharma plc. seller in Q4 2021 was Caxton Corporation, an estimated $16.4M sold.

Based on aggregated 13F filings for Q4 2021.